Page 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 20 - F ( Mark One ) □ REGISTRATION STATEMENT PURSUANT TO SECTION 12 ( b ) OR ( g ) OF THE SECURITIES EXCHANGE ACT OF 1934 OR × ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended December 31 , 2020 OR □ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from OR to SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report Commission file number : 001-36582 AURIS MEDICAL HOLDING LTD . ( Exact name of Registrant as specified in its charter ) Bermuda ( Jurisdiction of incorporation ) Clarendon House 2 Church Street Hamilton HM11 Bermuda ( Address of principal executive offices ) Thomas Meyer Tel : +1 ( 441 ) 295 59 50 Clarendon House 2 Church Street Hamilton HM11 Bermuda ( Name , Telephone , E - mail and / or Facsimile number and Address of Company Contact Person ) Copies to : Michael J. Lerner , Esq . Steven M. Skolnick , Esq . Lowenstein Sandler LLP 1251 Avenue of the Americas New York , NY 10020 Tel : ( 212 ) 262-6700 Securities registered or to be registered pursuant to Section 12 ( b ) of the Act : Title of each class Common Shares , par value CHF 0.01 per share Trading Symbol ( s ) EARS Name of each exchange on which registered The Nasdaq Stock Market LLC Securities registered or to be registered pursuant to Section 12 ( g ) of the Act : None ( Title of Class ) Securities for which there is a reporting obligation pursuant to Section 15 ( d ) of the Act :